Generic placeholder image

Current Drug Research Reviews

Editor-in-Chief

ISSN (Print): 2589-9775
ISSN (Online): 2589-9783

Review Article

Peptide Drugs: Current Status and Treatment for the Treatment of Various Diseases

Author(s): Chandni Chandarana*, Isha Juwarwala, Shravi Shetty and Anushree Bose

Volume 16, Issue 3, 2024

Published on: 17 April, 2024

Page: [381 - 394] Pages: 14

DOI: 10.2174/0125899775295960240406073630

Price: $65

Abstract

Peptides represent a class of natural molecules with diverse physiological functions, including hormone regulation, neurotransmission, and immune modulation. In recent years, peptide- based therapeutics have gained significant attention in pharmaceutical research and development due to their high specificity, efficacy, and relatively low toxicity. This review provides an overview of the current landscape of peptide drug development, highlighting the challenges faced in their formulation and delivery and the innovative strategies employed to overcome these hurdles. The review explores the wide range of applications of peptide drugs in treating various diseases, including HIV, multiple sclerosis, osteoporosis, chronic pain, diabetes, and cancer. Examples of FDA-approved peptide drugs and ongoing clinical trials are presented, showcasing the continuous advancements in peptide-based therapeutics across different therapeutic areas. This review underscores the promising potential of peptide drugs as targeted and effective treatments for a multitude of medical conditions, offering improved therapeutic outcomes and enhanced patient care.

Keywords: Peptide drugs, HIV, cancer, metabolic disorders, osteoporosis, diabetes.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy